Geode Capital Management’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $796K | Buy |
199,509
+2,211
| +1% | +$8.82K | ﹤0.01% | 3403 |
|
2025
Q1 | $519K | Buy |
197,298
+15,561
| +9% | +$40.9K | ﹤0.01% | 3530 |
|
2024
Q4 | $549K | Buy |
181,737
+31,061
| +21% | +$93.8K | ﹤0.01% | 3570 |
|
2024
Q3 | $506K | Buy |
150,676
+10,902
| +8% | +$36.6K | ﹤0.01% | 3575 |
|
2024
Q2 | $734K | Buy |
139,774
+2,318
| +2% | +$12.2K | ﹤0.01% | 3420 |
|
2024
Q1 | $748K | Buy |
137,456
+15,340
| +13% | +$83.5K | ﹤0.01% | 3467 |
|
2023
Q4 | $628K | Buy |
122,116
+29,409
| +32% | +$151K | ﹤0.01% | 3529 |
|
2023
Q3 | $500K | Buy |
92,707
+9,624
| +12% | +$51.9K | ﹤0.01% | 3603 |
|
2023
Q2 | $256K | Hold |
83,083
| – | – | ﹤0.01% | 3931 |
|
2023
Q1 | $393K | Hold |
83,083
| – | – | ﹤0.01% | 3739 |
|
2022
Q4 | $423K | Buy |
83,083
+908
| +1% | +$4.62K | ﹤0.01% | 3737 |
|
2022
Q3 | $516K | Buy |
82,175
+452
| +0.6% | +$2.84K | ﹤0.01% | 3705 |
|
2022
Q2 | $308K | Buy |
81,723
+1,678
| +2% | +$6.32K | ﹤0.01% | 4020 |
|
2022
Q1 | $509K | Hold |
80,045
| – | – | ﹤0.01% | 3923 |
|
2021
Q4 | $527K | Buy |
+80,045
| New | +$527K | ﹤0.01% | 4016 |
|
2021
Q3 | – | Sell |
-63,753
| Closed | -$437K | – | 4871 |
|
2021
Q2 | $437K | Buy |
63,753
+27,485
| +76% | +$188K | ﹤0.01% | 4004 |
|
2021
Q1 | $241K | Buy |
+36,268
| New | +$241K | ﹤0.01% | 4057 |
|